{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:20Z","timestamp":1707524720363},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,30]]},"DOI":"10.7759\/cureus.30867","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:44:11Z","timestamp":1667126651000},"source":"Crossref","is-referenced-by-count":1,"title":["Evaluating Ischemia-Modified Albumin as an Early Biomarker for Hypertensive Disorders During Pregnancy: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Jyoti  E","family":"John","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apurva","family":"Sakarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swayam Swaroop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchita","family":"Mundle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jancy","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra Chandra","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dnyanesh","family":"Amle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hypertension pathophysiology, diagnosis and management","author":"Barron WM","year":"1990","unstructured":"Barron WM, Murphy MB, Lindheimer MD. Hypertension pathophysiology, diagnosis and management. Management of hypertension during pregnancy. Laragh GH, Brenner BM (ed): Raven, New York; 1990. 2:1809-27."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa T","year":"2014","unstructured":"Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014, 10:466-80. 10.1038\/nrneph.2014.102","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2010.497879","article-title":"Ischemia-modified albumin as an oxidative stress marker in preeclampsia","volume":"24","author":"Ust\u00fcn Y","year":"2011","unstructured":"Ust\u00fcn Y, Engin-Ust\u00fcn Y, Ozt\u00fcrk O, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med. 2011, 24:418-21. 10.3109\/14767058.2010.497879","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref4","article-title":"Role of maternal serum ischemia modified albumin as a biochemical marker in preeclampsia","volume":"25","author":"Bahinipati J","year":"2014","unstructured":"Bahinipati J, Mohapatra PC, Pradhan T. Role of maternal serum ischemia modified albumin as a biochemical marker in preeclampsia. Biomed Res. 2014, 25:153-6.","journal-title":"Biomed Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijcbr.2019.046","article-title":"Serum ischemia modified albumin as a potent biochemical marker in pre-eclampsia patients attending a tertiary care hospital in central India","volume":"6","author":"Roy N","year":"2019","unstructured":"Roy N, Sahana S. Serum ischemia modified albumin as a potent biochemical marker in pre-eclampsia patients attending a tertiary care hospital in central India. Int J Clin Biochem Res. 2019, 6:209-12. 10.18231\/j.ijcbr.2019.046","journal-title":"Int J Clin Biochem Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.24.333","article-title":"Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia","volume":"24","author":"Gaze DC","year":"2009","unstructured":"Gaze DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet. 2009, 24:333-41. 10.2133\/dmpk.24.333","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1081\/PRG-100104165","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown MA","year":"2001","unstructured":"Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001, 20:IX-XIV. 10.1081\/PRG-100104165","journal-title":"Hypertens Pregnancy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(00)00255-9","article-title":"A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report","volume":"19","author":"Bar-Or D","year":"2000","unstructured":"Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000, 19:311-5. 10.1016\/s0736-4679(00)00255-9","journal-title":"J Emerg Med"},{"key":"ref9","article-title":"Impact of Pregnancy Induced Hypertension on Birth Weight of Newborn at Term","volume":"15","author":"Arshad A","year":"2011","unstructured":"Arshad A, Pasha W, Khattak TA, Kiyani RB. Impact of Pregnancy Induced Hypertension on Birth Weight of Newborn at Term. J of Rawalpindi Med College. 2011, 15:113-115.","journal-title":"J of Rawalpindi Med College"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90653-o","article-title":"National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy","volume":"163","year":"1990","unstructured":"National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990, 163.1691-712. 10.1016\/0002-9378(90)90653-o","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7860\/NJLM\/2022\/55717.2620","article-title":"Serum Lipid Profile Parameters as Markers of Oxidative Stress in Preeclampsia- A Case-control Study","volume":"11","author":"Sakarde A","year":"2022","unstructured":"Sakarde A, John J, Ahirwar AK, Hardas V. Serum Lipid Profile Parameters as Markers of Oxidative Stress in Preeclampsia- A Case-control Study. Nat Journal of Lab Med. 2022, 11:B025-9. 10.7860\/NJLM\/2022\/55717.2620","journal-title":"Nat Journal of Lab Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2009.83","article-title":"Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?","volume":"29","author":"Srinivas SK","year":"2009","unstructured":"Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?. J Perinatol. 2009, 29:680-4. 10.1038\/jp.2009.83","journal-title":"J Perinatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/BF02913070","article-title":"Ischemia modified albumin: A novel marker for acute coronary syndrome","volume":"21","author":"Chawla R","year":"2006","unstructured":"Chawla R, Goyal N, Calton R, Goyal S. Ischemia modified albumin: A novel marker for acute coronary syndrome. Indian J Clin Biochem. 2006, 21:77-82. 10.1007\/BF02913070","journal-title":"Indian J Clin Biochem"},{"key":"ref14","article-title":"Connection between ischemia\u2212modified albumin levels and markers of diabetic nephropathy and oxidative protein damage in type 2 diabetic patients","volume":"18","author":"Piwowar A","year":"2009","unstructured":"Piwowar A, Knapik-Kordecka M, Warwas M. Connection between ischemia\u2212modified albumin levels and markers of diabetic nephropathy and oxidative protein damage in type 2 diabetic patients. Adv Clin Exp Med. 2009, 18:353-60.","journal-title":"Adv Clin Exp Med"},{"key":"ref15","article-title":"Glycoxidative modification of albumin in medical research (Article in Polish)","volume":"34","author":"Grzebyk E","year":"2013","unstructured":"Grzebyk E, Piwowar A. Glycoxidative modification of albumin in medical research (Article in Polish). Pol Merkur Lekarski. 2013, 34:239-42.","journal-title":"Pol Merkur Lekarski"},{"key":"ref16","article-title":"Maternal serum ischemia modified albumin as a marker of oxidative stress in hypertensive disorders of pregnancy","volume":"23","author":"Kavitha S","year":"2019","unstructured":"Kavitha S, Lavanya Y. Maternal serum ischemia modified albumin as a marker of oxidative stress in hypertensive disorders of pregnancy. Indian J Med Biochem. 2019, 23:270-2.","journal-title":"Indian J Med Biochem"},{"key":"ref17","article-title":"Is ischemia modified albumin is a marker in Preeclampsia? A case control study in Kolar Population-a South West of India","volume":"3","author":"Dayanand CD","year":"2015","unstructured":"Dayanand CD, Bambrana V, Sivaraj N, Mary Shobha RI. Is ischemia modified albumin is a marker in Preeclampsia? A case control study in Kolar Population-a South West of India. American Journal of Pharmacy & Health Research. 2015, 3:84-90.","journal-title":"American Journal of Pharmacy & Health Research"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4274\/tjod.galenos.2020.23682","article-title":"The relationship between oxidative stress and preeclampsia. The serum ischemia-modified albumin levels and thiol\/disulfide homeostasis","volume":"17","author":"Onat T","year":"2020","unstructured":"Onat T, Aydo\u011fan K\u0131rm\u0131z\u0131 D, Ba\u015fer E, et al.. The relationship between oxidative stress and preeclampsia. The serum ischemia-modified albumin levels and thiol\/disulfide homeostasis. Turk J Obstet Gynecol. 2020, 17:102-7. 10.4274\/tjod.galenos.2020.23682","journal-title":"Turk J Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118577-evaluating-ischemia-modified-albumin-as-an-early-biomarker-for-hypertensive-disorders-during-pregnancy-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:21Z","timestamp":1707507801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118577-evaluating-ischemia-modified-albumin-as-an-early-biomarker-for-hypertensive-disorders-during-pregnancy-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.30867","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,30]]}}}